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A 67 year male had robotic prostatectomy whose pathology revealed mixed type prostate cancer
composed of 55% ductal and 45% acinar components. The patient was then admitted to hospital with
sudden health problems including ascites and serious vomiting attacks in the 46th month after pros-
tatectomy and the PSA test was 4565 ng/mL. Gastroscopic biopsy was reported and proved immunhis-
tochemically undifferentiated ductal prostate cancer metastasis. This is the ﬁrst report of late gastric
metastasis of ductal prostate cancer.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Prostatic ductal adenocarcinoma(PDA) is a rare histological
variant of prostate cancer (PC) that the prevalence of pure PDA
diagnosed with biopsy is around 0.4%e1% and 5% for mixed ductal
variants.1 PDA mainly arises from periurethral prostatic ducts, and
patients with this variant may present gross hematuria or urinary
obstructive symptoms. PDA has a worse prognosis than acinar
adenocarcinoma. In this case report, we aim to present a patient
with mixed PDA that had late gastric metastasis.Case report
We present a clinical case report of a 67 year-old patient with
unremarkable digital rectal examination had third biopsy was
performed because of rising prostate spesiﬁc antigen (PSA) levels
(6.3 ng/mL). The pathological investigation reported acinar PC with
a Gleason score 6 (3þ3), involving 30% of three cores. A pelvic MR
imaging demonstrated no extraprostatic extension and no metas-
tasis. Robotic radical prostatectomy was performed with an un-
eventful perioperative period. Pelvic lymphadenectomy was not, hhtavukcu@yahoo.com
Inc. This is an open access article uperformed because the patient was in a low risk group. Final pa-
thology revealed mixed type PC composed of 55% ductal and 45%
acinar components. The total cancer volume was 30% with negative
surgical margins (Fig. 1).
After regular follow-up with low PSA levels (0.05 ng/mL at the
6th month), at the 12th month a PSA value of 0.47 ng/mL was re-
ported and adjuvant pelvic radiotherapy was administered. After
this period PSA tests were in nadir till the 40th month. The patient
was then admitted to hospital with ascites and serious vomiting
attacks in the 46th month. The PSA test was 4565 ng/mL, the
creatinine level was 1.4 mg/dL, and MR imaging reported bilateral
high grade (2e3) hydronephrosis with enlarged pelvic lymph nodes
and multiple bone metastases(Fig. 2a). Parasynthesis was per-
formed due to massive ascites and at this period creatinine levels
elevated to 6 mg/dL. The histopathology of gastroscopic reported
undifferentiated prostate cancer metastasis(Fig. 2b). Immunohis-
tochemically, the neoplastic cells showed positive stains for alpha
methylacyl coenzyme A-reductase (AMACR) (Fig. 2c) and negative
for cytokeratin 7 (CK 7) which are the typical immunhistochemical
markers. AMACR is mainly expressed in PDA while CK 7, which is
secreted from basal cells, is a negative marker for PDA.
Metastases of bone, pelvic lymph nodes, and peritoneum were
also reported with MR imaging and regular parasynthesis per-
formed for abdominal distention. Maximal androgen deprivation
therapy was started immediately. After the injection of 11.25 mg of
leuprolide acetate, creatinine levels dramatically decreased tonder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. a. Stain of prostatic ductal adenocarcinoma; In the microscopic examination of the prostatectomy material, among the areas of classical prostatic acinar adenocarcinoma,
there were adenocarcinoma cells composed of malignant neoplastic proliferation with papillary and cribriform architecture. Complex, branching architecture typical of prostatic
ductal adenocarcinoma (H&E, 40). b. Acinar adenocarcinoma pattern; small atypical glands inﬁltrating in between larger glands (H&E, 40). c. Mixed pattern, ductal adenocar-
cinoma and acinar adenocarcinoma (H&E, 40).
Figure 2. a. MR imaging revealing bilateral hydronephrosis of kidney. b. Endoscopic scene of suspicious area in gastric fundus. c. Diffuse AMACR positivity is seen in nearly all
neoplastic cells that obtained from gastric biopsy (immunoperoxidase, 40).
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the MR imaging control. PSA levels decreased to 554 ng/mL in the
second month of maximal androgen blockage however in the third
month PSA levels were elevated to 839 ng/mL. After PSA elevation
docetaxel chemotherapy was started. It was decided to convert to
cabazitaxel regimen after the third cycle of docetaxel chemo-
therapy. Unfortunately in the second cycle of cabazitaxel treatment
the patient developed ileus and soon the patient died as a result of
the progression of symptoms.
Discussion
In comparisonwith classical acinar PC, PDA is a rare PC typewith
5%e10% of all PC. As most PDA patients display urinary symptoms,
our patient also had mild to moderate symptoms of urination that
were controlled with oral medication. Patients with PDA are re-
ported generally at the ages of 60e70 years as in our patient who
was 67 year-old. PDA is identiﬁed mostly in the central region due
to origin of prostatic ducts. In previous reports patients with PDA
present symptoms including macroscopic hematuria or urinary
retention.2 Conversely, our patient had no hematuria and urinary
retention at all.
Morgan et al3 reported patients with PDA that is independent of
other clinicopathological variables have twice the possibility to
have a lower PSA of 4.0 ng/mL. Our patient’s previous PSA was not
lower than 4.0 ng/mL at the beginning, and had no other high risk
ﬁndings of MR imaging. PDA is more likely to present distant
metastasis and in men with nondistant metastasis at diagnosis
ductal histology was associated with 2.2 fold disease speciﬁc
mortality.
After operation patient’s pathology was reported with mixed
type PDA; in current literature it was reported mostly after prostate
needle biopsy and then transurethral resection of prostate, and very
rarely after radical prostatectomy.1
The pathological grade of PDA tends to be higher and PDA is
usually identiﬁedwith Gleason pattern 4 and 5. Most of the patients
with PDA are in advanced disease, had poor prognosis and distant
metastasis.3 While our patient had nadir PSA levels until the 12th
month after the surgery, with a slightly elevated PSA of 0.47 ng/mL,
adjuvant radiotherapy was performed with the current dose of
72 cGy for local disease control in the 12th month.
Prostatic ductal adenocarcinoma is known to have a tendency to
metastases in distant sites and organs such as lung, rectum, testis,
penis, retrovesical space and retroperitoneal region, and sometimeswith cystic components.3 Previous reports also recommend paying
special attention to early bone or other visceral metastases.
Although gastric metastasis of prostatic acinar adenocarcinomawas
reported before to the best of our knowledge this is the ﬁrst case of
gastric metastasis with PDA that is reported in the literature.4
Hardie and colleagues reported a patient diagnosed with PDA to
rectal wall invasion that underwent neoadjuvant external beam
radiotherapy and concomitant hormonal therapy, MR imaging
response was marked. Then deﬁnitive prostatectomy and pelvic
exoneration was performed. In the pathology specimen there were
no evidence of positive surgical margins and lymph node metas-
tasis.5 In our case ﬁrst cancer relapse in the ﬁrst year when PSAwas
0.47 ng/mL, pelvic salvage extended lymphadenectomy might have
been performed before or after radiotherapy with concomitant
hormonal therapy; these approaches may contribute to better
survival.Conclusion
As loco regional progression is more common in PDA, late
distantmetastasis of PDAunfortunately has really fulminant clinical
progression as in our patient.Conﬂict of interest
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